Evidence map›Paper›PMID 39626082›Full record

ArticleJournal of lower genital tract disease2025

Cervical Cancer 2010-2019: An Upper Midwest Catchment of 40,000 Square Miles.

Keely K Ulmer, Peter L Wilson, Mark A Petereit, Michele Sargent, Kristin Cina, Lindsey Kroboth, Daniel G Petereit, Diane M Harper

Abstract read
In one paragraph

Article in Journal of lower genital tract disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Keely K UlmerUniversity of Iowa, Iowa City, IA.ORCID 0000-0003-4542-730
Peter L WilsonUniversity of South Dakota, Vermillion, SD.ORCID 0009-0000-6882-5883
Mark A PetereitUniversity of South Dakota Medical School, Vermillion SD.ORCID 0009-0005-4354-1207
Michele SargentWalking Forward/Avera, Rapid City, SD.ORCID 0009-0003-1630-835
Kristin CinaWalking Forward/Avera Research Institute, Rapid City, SD.ORCID 0009-0004-3789-3057
Lindsey KrobothUniversity of South Dakota Medical School, Vermillion SD.ORCID 0009-0004-5717-2388
Daniel G PetereitORCID 0000-0001-8886-6084
Diane M HarperDepartment of Family Medicine, Obstetrics and Gynecology, Women's and Gender Studies and Bioengineering, University of Michigan, Ann Arbor, MI, USA.ORCID 0000-0001-7648-883

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI THEODORE S LAWRENCE · 1988 to 2026
$178.2M
Michigan Institute for Clinical and Health Research (MICHR)UM1TR004404 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Julie C Lumeng · 2023 to 2026
$39.8M
NCATS NIH HHS UM1 TR004404NCI NIH HHS P30 CA046592
6 · The paper itself

Abstract

objectivesAmerican Indian (AI) women have a higher incidence and mortality from cervical cancer than non-Hispanic White (NHW) women in the US. This article's purpose is to detail the clinical events in the cervical cancer prevention continuum among the AI and White women with cervical cancer on the US frontier. MATERIALS AND

methodsA cancer center with a nearly 40,000 square-mile catchment area maintained a detailed cancer registry connected to the clinic records of all cervical cancer patients between 2010-2019. This catchment area provided records of both an AI and a White population. Descriptive and inferential statistics and modeling predictions detailed the prevention continuum.

resultsAmong the 126 with cervical cancer, 20% were AI, and 78% were White. Sixty percent did not participate in cervical cancer screening within the 5 years before their diagnosis, and on average, 9.2 years passed since the last cervical cancer screening. 91% presented with symptoms, and most women presented with 2 or more symptoms. Thirteen percent underwent a colposcopic diagnostic step, significantly delaying the time to diagnosis compared to other diagnostic steps. Sixty-nine percent of the histopathologic diagnoses were squamous cell carcinoma, and 27% were adenocarcinoma. Forty-nine percent presented at stage I regardless of histopathology. Chemotherapy and radiation therapy were most commonly combined. Sixty-three percent of the population survived, and 42% survived at least 3 years from diagnosis. Younger age and earlier stages at diagnosis were the significant adjusted predictors of survival.

conclusionsThe authors' detailed cervical cancer prevention continuum events provide new data questioning the use of colposcopy for women symptomatic at presentation.

Indexed as

Uterine Cervical NeoplasmsAdultAgedEarly Detection of CancerFemaleHumansMiddle AgedMidwestern United StatesYoung Adult

Identifiers

PMID39626082
PMCPMC11661925

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.